Levitt L J, Dawson D M, Rosenthal D S, Moloney W C
Cancer. 1980 Feb;45(3):545-52. doi: 10.1002/1097-0142(19800201)45:3<545::aid-cncr2820450322>3.0.co;2-6.
Instances of central nervous system (CNS) lymphomatous involvement occurring amongst 592 cases of non-Hodgkin's lymphoma (NHL) seen between 1967 and 1977 were reviewed. Lymphomatous complications of the CNS were found in 52 patients (9%): 24 with meningeal lymphoma, 20 with epidural compression and 8 with intracerebral lymphoma. Intracerebral lymphoma presented clinically as large parenchymal deposits of tumor unrelated to leptomeningeal disease. Ninety-eight percent (50/52) of all patients had a diffuse histologic subtype and 82% (42/52) had either histiocytic or diffuse, poorly differentiated lymphocytic lymphoma. Bone marrow involvement was an additional determinant of risk and aided in the selection of patients for possible CNS prophylaxis. Either meningeal or intracerebral lymphoma developed in 35% (6/17) of patients with diffuse histiocytic lymphoma and positive bone marrow biopsies. This subgroup was particularly felt to warrant CNS prophylaxis. Further diagnostic and therapeutic management regarding CNS involvement in NHL is discussed.
回顾了1967年至1977年间所见的592例非霍奇金淋巴瘤(NHL)患者中发生中枢神经系统(CNS)淋巴瘤累及的病例。52例患者(9%)出现了CNS淋巴瘤并发症:24例为脑膜淋巴瘤,20例为硬膜外压迫,8例为脑内淋巴瘤。脑内淋巴瘤临床上表现为与软脑膜疾病无关的肿瘤实质内大的肿块。所有患者中98%(50/52)为弥漫性组织学亚型,82%(42/52)为组织细胞性或弥漫性、低分化淋巴细胞性淋巴瘤。骨髓受累是另一个风险决定因素,有助于选择可能需要进行CNS预防的患者。弥漫性组织细胞性淋巴瘤且骨髓活检阳性的患者中35%(6/17)发生了脑膜或脑内淋巴瘤。这一亚组患者尤其被认为有必要进行CNS预防。文中还讨论了关于NHL患者CNS受累的进一步诊断和治疗管理。